| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,707 |
3,158 |
$242K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,665 |
1,640 |
$46K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
299 |
282 |
$30K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
265 |
265 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
112 |
112 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
843 |
818 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
63 |
63 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
108 |
103 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
293 |
278 |
$3K |
| 81003 |
|
1,185 |
1,173 |
$2K |
| 99173 |
|
889 |
887 |
$1K |
| 90461 |
|
39 |
39 |
$1K |
| 96127 |
|
256 |
256 |
$741.35 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
12 |
$644.92 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
109 |
104 |
$221.65 |
| 90686 |
|
239 |
239 |
$97.67 |
| 94760 |
|
38 |
33 |
$5.90 |
| 99000 |
|
153 |
148 |
$0.00 |